3 minute read

Bayshore Specialty RX

Next Article
Novartis

Novartis

BAYSHORE SPECIALTY RX, A LEADING CANADIAN SPECIALTY PHARMACY PROVIDER, IS USING INNOVATIVE Technology, Real-World Data (RWD) and Real-World Evidence (RWE) to enhance treatment plans and make a difference in the lives of Canadians with rare diseases. Thanks to proprietary tech platforms, including the My Bayshore Care, Vantage, and Digital Gateway™, Bayshore Specialty Rx can improve patient outcomes by providing better access to care, capturing more data, and enabling real-time monitoring of patients’ health.

“Our goal is to empower patients with rare diseases, their caregivers, and family with the knowledge and resources they need to manage their health. By leveraging our innovative tech platforms, we can capture more data on these patients and provide them with better access to care, ultimately improving their outcomes,” says Sean McBride, National Director of Operations at Bayshore Specialty Rx.

MyBayshoreCare is a digital platform that allows patients with rare diseases and their caregivers to access healthcare services from their homes, such as scheduling appointments, receiving care from licensed healthcare providers, and accessing educational resources. The platform also includes a mobile app that enables two-way communication with healthcare providers and the ability to track their progress, which facilitates capturing RWD to improve treatment plans.

Vantage is a remote monitoring platform that uses wearable devices to collect biometric data on patients’ vital signs, activity levels, and sleep patterns. This data is sent

to healthcare providers, who can use it to make informed decisions about treatment and adjust plans as needed. For patients with rare diseases, Vantage provides an efficient way to capture more data on their condition, enabling healthcare providers to understand their disease better and personalize treatment plans.

Digital Gateway™ provides healthcare practitioners with a quick and easy way to enroll patients in patient support

programs. Digital Gateway™ makes enrolling patients fast and easy by streamlining the data entry process from enrollment to reimbursement, improving data quality, and providing healthcare practitioners with visibility in the status of the application at every step of the way. By eliminating data entry redundancy and auto populating reimbursement forms, patients can get to treatment faster.

“By leveraging MyBayshoreCare, Vantage, and Digital Gateway™, Bayshore Specialty Rx is providing patients and caregivers with better access to care, enabling real-time health monitoring, and improving treatment plans for patients with rare diseases. As a leader in healthcare digital innovation, Bayshore Specialty Rx will continue to transform healthcare and improve patient outcomes for individuals with rare diseases,” says McBride.

To learn more about Bayshore Specialty RX, please click here bayshore.ca/BSRX.

This article is from: